Pharmaceutical Needs Assessment 2025 - 2028

Share Pharmaceutical Needs Assessment 2025 - 2028 on Facebook Share Pharmaceutical Needs Assessment 2025 - 2028 on Twitter Share Pharmaceutical Needs Assessment 2025 - 2028 on Linkedin Email Pharmaceutical Needs Assessment 2025 - 2028 link

The Pharmaceutical Needs Assessment (PNA) is a statutory document produced every three years to assess whether the provision of pharmacies and pharmaceutical services in Cheshire West and Chester is sufficient to meet the current and future needs of the local population. The PNA is mainly used by NHS England to ensure robustness in the awarding of new pharmacies and adjustment of existing pharmacy contracts.

Cheshire West and Chester’s Health and Wellbeing Board has produced the first draft of its 2025 Pharmaceutical Needs Assessment and we welcome your views on the accuracy of the PNA report. Your feedback is important as it will be used to help finalise the PNA which will be in place for the next three years.

Find out more

  • The full draft Pharmaceutical Needs Assessment is available to view here.
  • A summary of the draft Pharmaceutical Needs Assessment is also available to view here.
  • This information is also available in web-accessible format here.

Share your views

This consultation is open until 13 July 2025.

What happens next

Following consultation, responses will be reviewed by the multi-professional PNA steering group, which includes representatives from the Local Authority, Integrated Commissioning Board (ICB), Local Pharmaceutical Committee, Local Pharmaceutical Professional Network, Local Medical Committee, and Healthwatch.

The PNA will be amended as appropriate and the final PNA will include:

  • all responses to the consultation (no person will be identifiable),
  • the response to feedback by the steering group and/or Health and Wellbeing Board
  • a list of amendments or changes subsequently made to the PNA.

In September 2025 the revised PNA will be presented to the Health and Wellbeing Board for approval to publish. The final PNA will be published 1 October 2025 and will be available to view on the Cheshire West and Chester Council website.

The Pharmaceutical Needs Assessment (PNA) is a statutory document produced every three years to assess whether the provision of pharmacies and pharmaceutical services in Cheshire West and Chester is sufficient to meet the current and future needs of the local population. The PNA is mainly used by NHS England to ensure robustness in the awarding of new pharmacies and adjustment of existing pharmacy contracts.

Cheshire West and Chester’s Health and Wellbeing Board has produced the first draft of its 2025 Pharmaceutical Needs Assessment and we welcome your views on the accuracy of the PNA report. Your feedback is important as it will be used to help finalise the PNA which will be in place for the next three years.

Find out more

  • The full draft Pharmaceutical Needs Assessment is available to view here.
  • A summary of the draft Pharmaceutical Needs Assessment is also available to view here.
  • This information is also available in web-accessible format here.

Share your views

This consultation is open until 13 July 2025.

What happens next

Following consultation, responses will be reviewed by the multi-professional PNA steering group, which includes representatives from the Local Authority, Integrated Commissioning Board (ICB), Local Pharmaceutical Committee, Local Pharmaceutical Professional Network, Local Medical Committee, and Healthwatch.

The PNA will be amended as appropriate and the final PNA will include:

  • all responses to the consultation (no person will be identifiable),
  • the response to feedback by the steering group and/or Health and Wellbeing Board
  • a list of amendments or changes subsequently made to the PNA.

In September 2025 the revised PNA will be presented to the Health and Wellbeing Board for approval to publish. The final PNA will be published 1 October 2025 and will be available to view on the Cheshire West and Chester Council website.